journal
https://read.qxmd.com/read/38041862/cat-ownership-and-schizophrenia-related-disorders-and-psychotic-like-experiences-a-systematic-review-and-meta-analysis
#1
JOURNAL ARTICLE
John J McGrath, Carmen C W Lim, Sukanta Saha
BACKGROUND: It has been proposed that cat ownership may be a risk-modifying factor for schizophrenia-related disorders and psychotic-like experiences (PLE). This study aimed to systematically review and meta-analyze publications that reported the relationship between cat ownership and schizophrenia-related outcomes. METHODOLOGY: We searched Medline, Embase, CINAHL, Web of Science, and gray literature for publications between January 1, 1980, and May 30, 2023, regardless of geographical location and language...
December 2, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/38019938/childhood-adversity-determines-the-syndemic-effects-of-violence-substance-misuse-and-sexual-behavior-on-psychotic-spectrum-disorder-among-men
#2
JOURNAL ARTICLE
Yamin Zhang, Jeremy Coid
BACKGROUND AND HYPOTHESIS: Childhood adversity (CA) increases the risk for several adult psychiatric conditions. It is unclear why some exposed individuals experience psychotic symptoms and others do not. We investigated whether a syndemic explained a psychotic outcome determined by CA. STUDY DESIGN: We used self-reported cross-sectional data from 7461 British men surveyed in different population subgroups. Latent class analysis (LCA) identified categorical psychopathological outcomes...
November 29, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/38007605/disease-progression-patterns-of-brain-morphology-in-schizophrenia-more-progressed-stages-in-treatment-resistance
#3
JOURNAL ARTICLE
Daichi Sone, Alexandra Young, Shunichiro Shinagawa, Sakiko Tsugawa, Yusuke Iwata, Ryosuke Tarumi, Kamiyu Ogyu, Shiori Honda, Ryo Ochi, Karin Matsushita, Fumihiko Ueno, Nobuaki Hondo, Akihiro Koreki, Edgardo Torres-Carmona, Wanna Mar, Nathan Chan, Teruki Koizumi, Hideo Kato, Keisuke Kusudo, Vincenzo de Luca, Philip Gerretsen, Gary Remington, Mitsumoto Onaya, Yoshihiro Noda, Hiroyuki Uchida, Masaru Mimura, Masahiro Shigeta, Ariel Graff-Guerrero, Shinichiro Nakajima
BACKGROUND AND HYPOTHESIS: Given the heterogeneity and possible disease progression in schizophrenia, identifying the neurobiological subtypes and progression patterns in each patient may lead to novel biomarkers. Here, we adopted data-driven machine-learning techniques to identify the progression patterns of brain morphological changes in schizophrenia and investigate the association with treatment resistance. STUDY DESIGN: In this cross-sectional multicenter study, we included 177 patients with schizophrenia, characterized by treatment response or resistance, with 3D T1-weighted magnetic resonance imaging...
November 25, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/38000086/correction-to-predictors-of-mortality-following-a-schizophrenia-spectrum-diagnosis-evidence-from-the-20-year-follow-up-of-the-opus-randomized-controlled-trial
#4
(no author information available yet)
No abstract text is available yet for this article.
November 24, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37992246/the-development-of-non-affective-psychotic-syndromes-in-the-19th-century-legrand-du-saulle-and-his-1871-monograph-le-d%C3%A3-lire-de-pers%C3%A3-cutions-persecutory-delusions
#5
JOURNAL ARTICLE
Kenneth S Kendler, Virginia Justis
While the origins of two of Kraepelin's three subtypes of dementia praecox (DP), catatonic and hebephrenic, are well understood, no similar clear narrative exists for his concepts of paranoia and paranoid DP, which require a consideration of both German and French sources. An important milestone in the French literature is the massive 524 page monograph entitled "Le Délire Des Persécutions" published in 1871 by Henri Legrand du Saulle which contained extensive, clinically detailed descriptions of a wide range of cases with prominent, organized persecutory delusions...
November 22, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37992238/a-cross-sectional-conceptual-replication-and-longitudinal-evaluation-of-the-panss-autism-severity-score-measure-suggests-it-does-not-capture-autistic-traits-in-individuals-with-psychosis
#6
JOURNAL ARTICLE
Katharine Chisholm, Frederike Schirmbeck, Amy E Pinkham, Noah J Sasson, Claudia J P Simons, Lieuwe de Haan, Philip D Harvey, David L Penn, Tim Ziermans
BACKGROUND: Autism and psychosis co-occur at elevated rates, with implications for clinical outcomes, functioning, and suicidality. The PANSS-Autism-Severity-Score (PAUSS) is a measure of autism trait severity which has not yet been validated externally or longitudinally. STUDY DESIGN: Participants were derived from the GROUP and SCOPE datasets. Participants included 1448 adults with schizophrenia spectrum disorder (SSD), 800 SSD-siblings, 103 adults diagnosed with an autistic spectrum condition (ASC), and 409 typically-developing controls (TC)...
November 22, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37991994/correction-to-understanding-my-personal-schizophrenia
#7
(no author information available yet)
No abstract text is available yet for this article.
November 22, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37991982/correction-to-genome-wide-association-analysis-of-schizophrenia-and-vitamin-d-levels-shows-shared-genetic-architecture-and-identifies-novel-risk-loci
#8
(no author information available yet)
No abstract text is available yet for this article.
November 22, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37978044/associations-between-structural-covariance-network-and-antipsychotic-treatment-response-in-schizophrenia
#9
JOURNAL ARTICLE
Sakiko Tsugawa, Shiori Honda, Yoshihiro Noda, Cassandra Wannan, Andrew Zalesky, Ryosuke Tarumi, Yusuke Iwata, Kamiyu Ogyu, Eric Plitman, Fumihiko Ueno, Masaru Mimura, Hiroyuki Uchida, Mallar Chakravarty, Ariel Graff-Guerrero, Shinichiro Nakajima
BACKGROUND AND HYPOTHESIS: Schizophrenia is associated with widespread cortical thinning and abnormality in the structural covariance network, which may reflect connectome alterations due to treatment effect or disease progression. Notably, patients with treatment-resistant schizophrenia (TRS) have stronger and more widespread cortical thinning, but it remains unclear whether structural covariance is associated with treatment response in schizophrenia. STUDY DESIGN: We organized a multicenter magnetic resonance imaging study to assess structural covariance in a large population of TRS and non-TRS, who had been resistant and responsive to non-clozapine antipsychotics, respectively...
November 18, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37962384/consent-for-research-involving-spanish-and-english-speaking-latinx-adults-with-schizophrenia
#10
JOURNAL ARTICLE
Concepción Barrio, Dahlia Fuentes, Lize Tibiriçá, Mercedes Hernandez, Paula Helu-Brown, Shahrokh Golshan, Barton W Palmer
BACKGROUND: Latinxs are vastly underrepresented in mental health research; one of many contributing factors may be complexities in the research consent process, including language preferences. We examined determinants of comprehension of research consent procedures and tested the effects of a preconsent research schema condition among 180 adults with schizophrenia (60 Latinx-English and 60 Latinx-Spanish preference, and 60 non-Latinx White). STUDY DESIGN: Participants were randomly assigned (equal allocation) to an educational session regarding clinical research concepts and processes (schema condition) or to an attention control...
November 14, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37951838/clinical-assessment-interview-for-negative-symptoms-cains-a-systematic-review-of-measurement-properties
#11
JOURNAL ARTICLE
Sophia Wehr, Lucia Weigel, John Davis, Silvana Galderisi, Armida Mucci, Stefan Leucht
BACKGROUND AND HYPOTHESIS: Negative symptoms are very important for the overall loss of functioning observed in patients with schizophrenia. There is a need for valid tools to assess these symptoms. STUDY DESIGN: We used the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) systematic review guideline to evaluate the quality of the clinical assessment interview for negative symptoms (CAINS) as a clinician-rated outcome measurement (ClinROM)...
November 10, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37951230/corollary-discharge-dysfunction-as-a-possible-substrate-of-anomalous-self-experiences-in-schizophrenia
#12
JOURNAL ARTICLE
Rosa M Beño-Ruiz-de-la-Sierra, Antonio Arjona-Valladares, Marta Hernández-García, Inés Fernández-Linsenbarth, Álvaro Díez, Sabela Fondevila Estevez, Carolina Castaño, Francisco Muñoz, Javier Sanz-Fuentenebro, Alejandro Roig-Herrero, Vicente Molina
BACKGROUND AND HYPOTHESIS: Corollary discharge mechanism suppresses the conscious auditory sensory perception of self-generated speech and attenuates electrophysiological markers such as the auditory N1 Event-Related Potential (ERP) during Electroencephalographic (EEG) recordings. This phenomenon contributes to self-identification and seems to be altered in people with schizophrenia. Therefore, its alteration could be related to the anomalous self-experiences (ASEs) frequently found in these patients...
November 10, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37931622/can-the-predictive-processing-framework-explain-the-persistence-of-delusional-beliefs
#13
JOURNAL ARTICLE
Benjamin R H Cook, Juliet D Griffin
No abstract text is available yet for this article.
November 1, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37929893/targeted-treatment-of-schizophrenia-symptoms-as-they-manifest-or-continuous-treatment-to-reduce-the-risk-of-psychosis-recurrence
#14
JOURNAL ARTICLE
Michael Davidson, William T Carpenter
Current pharmacological treatment of schizophrenia employs drugs that interfere with dopamine neurotransmission, aiming to suppress acute exacerbation of psychosis and maintenance treatment to reduce the risk of psychosis recurrence. According to this treatment scheme, available psychotropic drugs intended to treat negative symptoms, cognitive impairment, or anxiety are administered as add-ons to treatment with antipsychotics. However, an alternative treatment scheme proposes a targeted or intermittent treatment approach, by which antipsychotic drugs are administered upon psychosis exacerbation and discontinued upon remission or stabilization, while negative symptoms, cognitive impairment, or anxiety are treated with specific psychotropics as monotherapy...
October 31, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37921353/the-effect-of-accelerated-continuous-theta-burst-stimulation-on-weight-loss-in-overweight-individuals-with-schizophrenia-a-double-blind-randomized-sham-controlled-clinical-trial
#15
JOURNAL ARTICLE
Dongyu Kang, Yi Zhang, Guowei Wu, Chuhan Song, Xinjie Peng, Yujun Long, Guo Yu, Hui Tang, Yawei Gui, Quan Wang, Tifei Yuan, Renrong Wu
BACKGROUND AND HYPOTHESIS: Obesity is a common comorbidity in individuals with schizophrenia and is associated with poor clinical outcomes. At present, there are limited effective approaches for addressing this issue. We conducted a double-blind, randomized, sham-controlled clinical trial to investigate the efficacy of noninvasive magnetic stimulation techniques in reducing obesity in individuals with schizophrenia. STUDY DESIGN: Forty overweight individuals with schizophrenia were recruited and randomly assigned to receive either the active or sham intervention...
October 31, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37901911/a-transdiagnostic-study-of-effort-cost-decision-making-in-psychotic-and-mood-disorders
#16
JOURNAL ARTICLE
Adam J Culbreth, Erin K Moran, Wasita Mahaphanit, Molly A Erickson, Megan A Boudewyn, Michael J Frank, Deanna M Barch, Angus W MacDonald, J Daniel Ragland, Steven J Luck, Steven M Silverstein, Cameron S Carter, James M Gold
BACKGROUND: Research suggests that effort-cost decision-making (ECDM), the estimation of work required to obtain reward, may be a relevant framework for understanding motivational impairment in psychotic and mood pathology. Specifically, research has suggested that people with psychotic and mood pathology experience effort as more costly than controls, and thus pursue effortful goals less frequently. This study examined ECDM across psychotic and mood pathology. HYPOTHESIS: We hypothesized that patient groups would show reduced willingness to expend effort compared to controls...
October 30, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37897399/up-regulation-of-the-trace-amine-receptor-taar-1-in-the-prefrontal-cortex-of-individuals-affected-by-schizophrenia
#17
JOURNAL ARTICLE
Tiziana Imbriglio, Marika Alborghetti, Valeria Bruno, Giuseppe Battaglia, Ferdinando Nicoletti, Milena Cannella
BACKGROUND AND HYPOTHESIS: Type-1 trace amine-associated receptors (TAAR1) modulate dopaminergic and glutamatergic neurotransmission and are targeted by novel antipsychotic drugs. We hypothesized that schizophrenia (SCZ) causes adaptive changes in TAAR1 expression in the prefrontal cortex. STUDY DESIGN: We measured TAAR1 mRNA and protein levels by quantitative PCR and immunoblotting in post-mortem prefrontal cortical samples obtained from 23 individuals affected by SCZ and 23 non-schizophrenic controls (CTRL)...
October 28, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37863120/refining-the-diagnostic-criteria-for-schizophrenia-an-infinite-task
#18
JOURNAL ARTICLE
Josef Parnas, Annick Urfer Parnas
No abstract text is available yet for this article.
October 20, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37861424/violent-offending-in-males-with-or-without-schizophrenia-a-role-for-social-cognition
#19
JOURNAL ARTICLE
Anja Vaskinn, Jaroslav Rokicki, Christina Bell, Natalia Tesli, Nina Bang, Gabriela Hjell, Thomas Fischer-Vieler, Unn K Haukvik, Christine Friestad
BACKGROUND AND HYPOTHESIS: Reduced social cognition has been reported in individuals who have committed interpersonal violence. It is unclear if individuals with schizophrenia and a history of violence have larger impairments than violent individuals without psychosis and non-violent individuals with schizophrenia. We examined social cognition in two groups with violent offenses, comparing their performance to non-violent individuals with schizophrenia and healthy controls. STUDY DESIGN: Two social cognitive domains were assessed in four groups: men with a schizophrenia spectrum disorder with (SSD-V, n = 27) or without (SSD-NV, n = 42) a history of violence, incarcerated men serving preventive detention sentences (V, n = 22), and healthy male controls (HC, n = 76)...
October 20, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37861419/combinations-and-temporal-associations-among-precursor-symptoms-before-a-first-episode-of-psychosis
#20
JOURNAL ARTICLE
Vincent Paquin, Ashok K Malla, Srividya N Iyer, Martin Lepage, Ridha Joober, Jai L Shah
BACKGROUND AND HYPOTHESIS: Symptoms that precede a first episode of psychosis (FEP) can ideally be targeted by early intervention services with the aim of preventing or delaying psychosis onset. However, these precursor symptoms emerge in combinations and sequences that do not rest fully within traditional diagnostic categories. To advance our understanding of illness trajectories preceding FEP, we aimed to investigate combinations and temporal associations among precursor symptoms. STUDY DESIGN: Participants were from PEPP-Montréal, a catchment-based early intervention program for FEP...
October 20, 2023: Schizophrenia Bulletin
journal
journal
22417
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.